SCHEMBL8784689

SCHEMBL8784689

CCC(C1CCCCC1)C(C(C)=O)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SHBG P04278 2/20 0.55
EPHX1 P07099 3/20 0.37
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
IDO1 P14902 1/20 0.33
TSHR P16473 1/20 0.32
EPHX2 P34913 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CPN1 P15169 1/20 0.31
CPB2 Q96IY4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8330847 0.91 SHBG (0.61) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL16732011 0.89 SHBG (0.58) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL11226733 0.81 SHBG (0.50) SHBGALDH1A1TSHRL3MBTL1KDM4E
SCHEMBL11070281 0.81 SHBG (0.50) SHBGALDH1A1TSHRL3MBTL1KDM4E
SCHEMBL10646074 0.78 SHBG (0.59) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL1227604 0.78 SHBG (0.59) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL8330418 0.77 SHBG (0.44) SHBGEPHX1ALDH1A1SMN1; SMN2TSHR
SCHEMBL288891 0.76 SHBG (0.57) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL28758251 0.76 SHBG (0.57) SHBGEPHX1ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL16732332 0.75 SHBG (0.55) SHBGEPHX1ALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0506478-B1 Piperidine derivatives LILLY CO ELI (US) 1997-09-03 EP disclosed
US-5250542-A Prevention of side effects induced by narcotics used as analgesics such as constipation, nausea and vomiting; 1-carboxyalkyl-4-methyl-4-(3-oxyphenyl)piperidines such as alvimopan ELI LILLY AND COMPANY (US) 1993-10-05 US disclosed
EP-0506478-A1 Piperidine derivatives ELI LILLY AND COMPANY (US) 1992-09-30 EP disclosed